tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CMMB Stock Latest News

Chemomab Therapeutics Announces Key Decisions from Annual Shareholders Meeting
Company AnnouncementsChemomab Therapeutics Announces Key Decisions from Annual Shareholders Meeting
23d ago
6K
CMMB
Chemomab Therapeutics announces data from Phase 2 SPRING trial of nebokitug
PremiumThe Fly
Chemomab Therapeutics announces data from Phase 2 SPRING trial of nebokitug
25d ago
CMMB
Chemomab obtained feedback from two recent FDA meetings on nebokitug
PremiumThe Fly
Chemomab obtained feedback from two recent FDA meetings on nebokitug
1M ago
CMMB
Chemomab announces nebokitug awarded new patent protection in China, Russia
PremiumThe Fly
Chemomab announces nebokitug awarded new patent protection in China, Russia
2M ago
CMMB
Chemomab Therapeutics Announces Annual General Meeting for July 2025
PremiumCompany Announcements
Chemomab Therapeutics Announces Annual General Meeting for July 2025
2M ago
6K
CMMB
Chemomab Therapeutics: Promising Prospects with Streamlined Path to Approval and Strategic Advancements
PremiumRatingsChemomab Therapeutics: Promising Prospects with Streamlined Path to Approval and Strategic Advancements
2M ago
CMMB
Chemomab Therapeutics Advances Nebokitug for PSC Treatment
Premium
Company Announcements
Chemomab Therapeutics Advances Nebokitug for PSC Treatment
2M ago
CMMB
Chemomab Therapeutics price target lowered to $10 from $11 at Oppenheimer
Premium
The Fly
Chemomab Therapeutics price target lowered to $10 from $11 at Oppenheimer
2M ago
CMMB
Chemomab Therapeutics Advances Nebokitug Towards Phase 3 After Positive Trial Results
PremiumCompany Announcements
Chemomab Therapeutics Advances Nebokitug Towards Phase 3 After Positive Trial Results
2M ago
6K
CMMB
Chemomab Therapeutics reports Q1 EPS $0.007 vs $0.014 last year
PremiumThe Fly
Chemomab Therapeutics reports Q1 EPS $0.007 vs $0.014 last year
2M ago
CMMB
Chemomab Therapeutics: Promising Phase 2 Data and Attractive Entry Point Justify Buy Rating
PremiumRatings
Chemomab Therapeutics: Promising Phase 2 Data and Attractive Entry Point Justify Buy Rating
3M ago
CMMB
Chemomab Therapeutics announces presentation of Phase 2 data of CM-101
PremiumThe Fly
Chemomab Therapeutics announces presentation of Phase 2 data of CM-101
3M ago
CMMB
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
NVS
BCDA
Chemomab Therapeutics reports new clinical data at EASL 2025 on nebokitug
Premium
The Fly
Chemomab Therapeutics reports new clinical data at EASL 2025 on nebokitug
3M ago
CMMB
Chemomab Announces Key Leadership Changes Amid Successful Trial Completion
Premium
Company Announcements
Chemomab Announces Key Leadership Changes Amid Successful Trial Completion
3M ago
6K
CMMB
Chemomab Therapeutics appoints Weiner as interim CMO, Lawler as CDO
PremiumThe Fly
Chemomab Therapeutics appoints Weiner as interim CMO, Lawler as CDO
3M ago
CMMB
Promising Phase 3 Prospects and Strategic Study Design Justify Buy Rating for Chemomab Therapeutics
PremiumRatings
Promising Phase 3 Prospects and Strategic Study Design Justify Buy Rating for Chemomab Therapeutics
4M ago
CMMB
Chemomab’s Nebokitug Shows Promising Phase 2 Results for PSC
PremiumCompany Announcements
Chemomab’s Nebokitug Shows Promising Phase 2 Results for PSC
4M ago
6K
CMMB
Chemomab Therapeutics reports results in nebokitug Phase 2 PSC OLE trial
PremiumThe Fly
Chemomab Therapeutics reports results in nebokitug Phase 2 PSC OLE trial
4M ago
CMMB
Chemomab Therapeutics Updates ADS Offering Under Sales Agreement
PremiumCompany AnnouncementsChemomab Therapeutics Updates ADS Offering Under Sales Agreement
4M ago
6K
CMMB
Chemomab Therapeutics Reports 2024 Financial Results and Progress
Premium
Company Announcements
Chemomab Therapeutics Reports 2024 Financial Results and Progress
5M ago
CMMB
Chemomab Therapeutics announces new scientific presentation on nebokitug
Premium
The Fly
Chemomab Therapeutics announces new scientific presentation on nebokitug
5M ago
CMMB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >